Published Date: August, 2017
A recent report published by Infinium Global Research on infectious disease testing market provides in depth analysis of segments and sub-segments in global as well as regional infectious disease testing market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional infectious disease testing market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global infectious disease testing market. According to report the global infectious disease testing market is projected to grow at a CAGR of 8.3% over the forecast period of 2017-2023.
Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful, but under certain conditions, some organisms may cause disease. Some infectious diseases can be passed from person to person. Some are diffused by bites from insects or animals. And others are acquired by feeding contaminated food or water or being exposed to organisms in the environment. Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild infections may respond to rest and home remedies, while some life-threatening infections may require hospitalization. Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines. Early diagnosis and treatment of these infectious diseases will play a crucial role in avoiding long-term complications. Molecular testing, microbiology and immunodiagnostics are the key diagnosis methods available.
Figure 1: Global Infectious Disease Testing Market by Value 2015-2023
Rise in base of geriatric population, increasing awareness among the population about communicable diseases, reducing immunity levels, growing prevalence of infectious diseases and rise in demand for point of care diagnostics are the key driving factors for the growth of this market. In addition, increased adoption of advanced technologies, shifting healthcare trend towards more precise, safer and effective diagnosis and advances in molecular biology are creating lucrative growth opportunities in the coming years.
The report on global infectious disease testing market covers segments such as, technology, product, application and end user. On the basis of technology the global infectious disease testing market is categorized into molecular testing, microbiology and immunodiagnostics. On the basis of product the global infectious disease testing market is categorized into equipment, reagents and software. On the basis of application the global infectious disease testing market is categorized into hepatitis, HIV, methicillin-resistant staphylococcus aureus (MRSA) infection, human papillomavirus (HPV), respiratory tract infections and others. On the basis of end user the global infectious disease testing market is categorized into hospitals laboratories, reference labs, physician office labs, academics lab and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
Figure 2: Global Infectious Disease Testing Market by Region, CAGR % 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global infectious disease testing market such as, Abbott Laboratories, Becton, Dickinson & Co, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthcare, Roche Diagnostics, Gen-Probe, Inc., Johnson and Johnson, bioMeriux SA and Alere, Inc.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global infectious disease testing market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of infectious disease testing market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the infectious disease testing market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the infectious disease testing market to understand the present and future trends in this market and formulate their strategies accordingly.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter